Resetting the immune system in severe autoimmune diseases with immuno- ablation followed by autologous stem cell transplantation using enriched CD34 + cells is associated with long-term remissions - a 15-year single-center experience

Unless otherwise specifically indicated, Miltenyi Biotec products and services are for research use only and not for therapeutic or diagnostic use. CliniMACS, MACS, the MACS logo, and MACSQuant are registered trademarks or trademarks of Miltenyi Biotec GmbH. All other trademarks mentioned in this document are the property of their respective owners and are used for identification purposes only. Copyright © 2014 Miltenyi Biotec GmbH. All rights reserved. Excerpt from MACS&more Vol 16–1/2014